Layne Jacobs assists clients with a broad range of business activities, including M&A, private and public financings, securities law compliance and corporate governance.

Download full bio 

Experience

  • Turnstone Biologics to Acquire Myst Therapeutics 

  • Inventiva – $108 Million IPO 

  • Zentalis Pharmaceuticals - $190 Million IPO 

  • Milestone Pharmaceuticals – $95 Million IPO 

  • Datto Agrees to Sale with Vista Equity Partners, Merger with Autotask 

  • View all

Education

  • Harvard Law School
    JD, 2014

  • Yale University
    PhD, Religious Studies
    2014

  • Duke Divinity School
    MTS

  • Southern Nazarene University
    BA


Admissions & Credentials

Massachusetts